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Qi Wang, Yongping Bao, Xiaohong Zhang, Paul R. Coxon, Upali A. Jayasooriya,  
and Yimin Chao*Poly-acrylic acid (PAAc) terminated silicon nanoparticles (SiNPs) have been 
synthesized and employed as a synchronous fluorescent signal indicator in a 
series of cultured mammalian cells: HHL5, HepG2 and 3T3-L1. Their bio-
logical effects on cell growth and proliferation in both human and mouse cell 
lines have been studied. There was no evidence of in vitro cytotoxity in the 
cells exposed to PAAc terminated SiNPS when assessed by cell morphology, 
cell proliferation and viability, and DNA damage assays. The uptake of the 
nanocrystals by both HepG2 and 3T3-L1 cells was investigated by confocal 
microscopy and flow cytometry, which showed a clear time-dependence 
at higher concentrations. Reconstructed 3-D confocal microscope images 
exhibited that the PAAc-SiNPs were evenly distributed throughout the cytosol 
rather than attached to outer membrane. This study provides fundamental 
evidence for the safe application and further modification of silicon nanopar-
ticles, which could broaden their application as cell markers in living systems 
and in micelle encapsulated drug delivery systems.1. Introduction
The study of nanoparticles (NPs) has significantly increased 
in the past decade and has attracted interest from a wide field 
across the scientific community.[1–6] Owing to the flexibility of 
manufacturing methods which can yield NPs of different sizes, 
shapes and surface modifications, specially engineered NPs © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, WeinheimAdv. Healthcare Mater. 2012, 1, 189–198
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Zhejiang, 315211, P. R. Chinacan be used in a variety of applications; 
not least in biological imaging[3,7–9] where 
information on cellular components and 
processes is typically visualised by fluo­
rescence microscopic imaging. This is 
done by attaching fluorophores to mole­
cules which bind to the desired targets via 
molecular recognition pathways and allow 
the system of interest to be imaged.[10,11] 
Traditionally organic dyes and fluorescent 
proteins serve as the fluorophore in most 
biological systems as they are highly water 
soluble and bioconjugate with the intended 
target easily.[10] However, the rapid devel­
opment of biomedical sciences now 
demands new advanced techniques and 
instruments.[10,11] Semiconductor nano­
particles have several advantages over and 
above dye and protein­based labels making 
them ideal candidates to replace current 
imagine techniques in many biological assays and fluorescence imaging routines,[7] such as tunable 
fluorescence signatures,[12–14] high quantum efficiency[15] and 
stability against photobleaching.[16,17] As the range and extent 
of nanoparticle applications has risen over time, the security 
and biological effects of nanomaterials within organic media 
have emerged as a new focus of research. Small nanoparticles 
(with diameters of <10 nm) can act as effective drug carriers in 
cancer therapies since they can more readily diffuse throughout 
the tumor tissue’s interstitial space.[1] These require a thor­
ough understanding of the mechanisms involved in the cellular 
uptake, and the intracellular localization for the various types of 
nanoparticles used.[18,19] In addition, it is essential that NPs are 
water soluble and hydrophilic to prevent aggregation and pre­
cipitation in the biological environment. The most widely used 
and best understood nanoparticle fluorophores are based on 
CdS, CdSe, CdTe, or ZnS.[8,10,11] However, in vitro studies sug­
gest that under certain conditions these classes of nanoparti­
cles may be cytotoxic.[20] The cytotoxicity is mainly attributed to 
the leaching of heavy metal ions such as Cd2+, although some 
reports indicate the formation of free radicals which lead to cell 
death.[21,22] Owing to their low inherent toxicity,[23] silicon nano­
particles (SiNPs) have the potential to overcome the inherent 
limitation of heavy metal nanoparticles in biomedical applica­
tions. As a result, research on the biological effects of SiNPs 189wileyonlinelibrary.com
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190has grown in importance and gained extensive attention. To 
address these problems we have synthesized poly­acrylic acid 
terminated silicon nanoparticles (PAAc­SiNPs) that are chemi­
cally stable and exhibit strong red luminescence.[24,25] The bio­
compatibility of PAAc­SiNPs and cytotoxicity are important 
parameters to evaluate whether these SiNPs can be used safely 
in biomedical environments. In order to establish if the PAAc­
SiNPs can be employed to study intracellular functions without 
disrupting cellular activity, we have carried out in vitro cellular 
studies using a variety of cell lines. The study was designed to 
determine the potential cytotoxicity and cellular uptake effi­
ciency against incubation time and SiNP concentration. These 
intensely fluorescent PAAc­SiNPs were found to accumulate in 
the cytosols and showed no significant cytotoxicity.
2. Results
2.1. Physical Characteristics of PAAc-SiNPs
The SiNPs studied in this work are composed of a crystalline 
silicon core capped with a poly­acrylic acid layer. Hydrogen­ 
terminated silicon surfaces were produced by galvanostatic ano­
dization in a 1:1 HF:ethanol solution. The Si­H surface bond 
can then be treated with poly­acrylic acid to form hydrophilic 
silicon nanoparticles (Figure 1a). The SiNPs display intense wileyonlinelibrary.com © 2012 WILEY-VCH Verlag G
Figure 1. (a) Schematic representation of the hydrosilylation of silicon 
nanoparticles in acrylic acid. Surface Si atoms of the nanoparticles change 
from H- to PAAc termination under UV illumination; (b) DLS distribu-
tion curves of silicon nanoparticles suspended in PBS (10.5 ± 3.0 nm), 
0.2 μnm pore size filtration was applied before the measurement.
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(b) luminescence under excitation with λex = 310 nm light. The 
emission spectrum is centred at 600 nm and is independent 
of the excitation wavelength.[25] The SiNPs are hydrophilic and 
therefore have relatively high miscibility in polar solvents. The 
SiNPs were found to be readily suspended in a range of solvents 
including water, ethanol and phosphate­buffered saline (PBS).
Dynamic light scattering (DLS) measurements revealed the 
main diameter of these particles in PBS to be 10.5 ± 3.0 nm 
(Figure 1b), which is larger than AFM results reported on the 
samples previously,[25] and HRTEM results (see supporting 
information). This is because DLS is measuring the hydrody­
namic diameter of the particle, thus effectively measuring the 
nanoparticle and anything affiliated with its surface which 
could be a surrounding double­layer, capping agents, or nano­
particle aggregates. The DLS measurements also confirm that 
the hydrodynamic diameter of the particles remains practi­
cally unchanged after dispersion in water for at least 4 days 
(see supporting information). The stability of the poly­acrylic 
acid capped SiNPs has been monitored over periods of several 
months which showed that the samples remain very stable if 
they are stored in a dark and radiation free environment, which 
is in line with the results from other group.[26,27] The photo­
luminescence in PBS obtained over 4 weeks is shown in sup­
porting information.
Chemical bonding of SiNPs with poly­acrylic acid ligands 
was investigated by high­resolution X­ray photoelectron spec­
troscopy (XPS) over the Si2p, C1s and O1s regions of the SiNPs 
(Figure 2 and Figure S3). The Si2p spectrum (Figure 2) was 
fitted with three mixed Gaussian­Lorentzian doublets against a 
Shirley background profile. The first component at 100 eV is 
assigned to Si–Si bonding within the silicon core of the SiNPs. 
The second at 102 eV is from Si­C and the third at 104 eV from 
SiO2 at the surface of SiNPs, respectively.[28] XPS spectra over 
the C1s and O1s regions can be found in supporting informa­
tion. By the presence of a Si­C component in the Si2p region mbH & Co. KGaA, Weinheim Adv. Healthcare Mater. 2012, 1, 189–198
Figure 2. XPS core-level spectrum the Si2p regionof Si-NPs obtained at 
normal emission with a photon energy 1486.7 eV: the dotted lines are 
experimental data that were fitted by peaks with a mixed linear combina-
tion of Gaussian-Lorentzian function profiles.
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Figure 3. Effect of PAAc-SiNPs on cell proliferation and viability. HepG2 
cells were treated with PAAc-SiNPs (0.1–200 μg·mL−1) for 24 hours (white 
columns) and 48 hours (dark columns) and the proliferation of cells was 
determined by MTT assay (a) and viability of cells was measured by typan 
blue staining (b). There was no evidence of acute cytotoxicity, as evident 
from trypan blue assay performed on HepG2. (c) HepG2 (white column), 
HHL5 (light gray column), 3T3-L1 pre-adipocyte (gray wide downward 
diagonal column), and 3T3-L1 mature adipocyte (dark column) cells were 
exposed to indicated concentration of SiNPs for 48 hours. Cell prolif-
eration was determined by MTT assay. The data are expressed as the 
percentage of cell viability compared with the untreated control and rep-
resent the mean ±SD of three independent experiments.
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(c) MTTwe can deduce the surface silicon atoms of the NPs have under­
gone H­ to poly­acrylic acid termination.[12] Clearly the peak at 
104 eV suggests the presence of surface oxide and from the rel­
ative area each peak component contributes to the overall fitted 
spectrum (indicated within the figure) we can determine, to a 
first approximation, the degree of PAAc coverage within the 
samples. By the fit performed we estimate 83% of the silicon 
surface is bound by Si­C bonds to the PAAc capping layer while 
the remaining 17% is surface oxide. This compares favour­
ably with SiNPs surfaces bound by organic monolayers chains 
where 50% surface coverage is typical.[29,30] The degree of oxi­
dation listed here is a qualitative estimation based upon the 
structure and chemical makeup of the nanoparticles studied in 
the work presented here. While it is true that the degree of sur­
face oxidation of silicon nanostructures will play a role in the 
electronic density of states and consequently the photolumines­
cence profile,[31,32] such studies are not presented here and are 
thus a course for future research upon PAAc capped SiNPs.
2.2. In vitro Cytotoxicity Assays
Different type of nanoparticles possesses their own particular 
physicochemical properties, which in turn determines their 
potential toxicity or lack thereof. The effect of PAAc­SiNPs on 
the proliferation and viability of cells was determined by MTT 
assay and trypan blue stain respectively. HHL­5 (immortalised 
human hepatocytes), HepG2 (human liver hepatocellular carci­
noma), 3T3­L1 (mouse embryonic fibroblast ­ adipose like cell 
line) cells were plated in 200 μl of complete culture medium 
containing 0.1–200 μg·mL−1 concentrations of PAAc­SiNPs 
in 96­well plates for 24 and 48 hours. There was no evidence 
of morphology change when the cells were observed under a 
phase­contrast microscope. The values of cytotoxicity induced 
by PAAc­SiNPs are given in Figure 3. As shown in Figure 3a, 
treatment with poly­acrylic acid functionalized nanoparticles 
(0­200 μg·mL−1) did not markedly effect the proliferation of 
HepG2cells. PAAc­SiNP treatment (0–200 μg·mL−1) did not 
result in a dose­dependent inhibition of cell growth, when com­
pared to vehicle­treated controls. PAAc­SiNP treatment also 
resulted in no time dependent inhibition of the cells’ growth. 
As shown in Figure 3b, the trypan blue cell viability assay also 
suggested lack of cytotoxic effects of PAAc­SiNPs upon the 
cells, which is consistent with the pattern in the MTT assay 
(Figure 3a).
Furthermore, the results from the MTT assay (Figure 3c) 
suggest the PAAc­SiNPs did not cause any apparent harm to 
the proliferation of the different types of cells (both human 
and mouse cells lines). There were no significant differences 
(p > 0.05) in the cell proliferation and viability between PAAc­
SiNP treated and control cells.
To assess the effects of PAAc­SiNP on DNA damage, PAAc­
SiNP treated HepG2 and HHL­5 cells were analyzed by alka­
line comet assays to monitor total DNA strand breaks.[33] 
Figure 4 shows the results on HepG2 cells. Exposing cells to 
50 μM H2O2 (positive control) followed by a 1 hour incubation 
period, resulted in a high level of DNA damage, visualised as 
comets, see Figure 4b, such that about half DNA was in the 
tail. However, in PAAc­SiNP treated cells, no significant comet © 2012 WILEY-VCH Verlag GAdv. Healthcare Mater. 2012, 1, 189–198tail formation was be observed, indicating no significant DNA 
strand breakage, see Figure 4c and Figure 4d. This result sug­
gests our nanoparticles do not induce oxidative DNA damage 
in the cells, which combined with MTT cell viability results, if 191wileyonlinelibrary.commbH & Co. KGaA, Weinheim
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Figure 4. PAAc-SiNP effect on DNA damage in HepG2 cells were analyzed with the comet assay: (a) negative control, cell incubated with medium only; 
(b) positive control, cells were exposed to 50 μM H2O2 for 1 h; (c) cells were treated with 100 μg · mL−1 PAAcSiNPs for 1 hour; (d) PAAc-SiNP dose 
effect of the extent of DNA damage. Damage is expressed in tail moment analyzed by Comet IV software. The values are the mean ± S.E. of 60 cells.follows the PAAc­SiNPs have no cytotoxic effects on the cells, 
ands may be deemed safe to use as a potential fluorescent probe 
in bioimaging assays. Comet assay results on HHL­5 cells can 
be found in supporting information Figure S4.
2.3. Uptake of PAAc-SiNPs in Cultured Mammalian Cells
Cultured cells can take up nanoparticles when they were incu­
bated together, but the ability to become internalized within 
cells is different for different types of nanoparticles. Confocal 
microscopy and flow cytometry were used to study the uptake 
of PAAc­SiNPs in the various cell lines. Figure 5 shows a con­
focal image of HepG2 incubated with 50 or 100 μg·mL−1 SiNPs 
for different incubation times. After being incubated for 1 hour, 
it was found that PAAc­SiNPs began to accumulate in the cell 
at the concentration of 100 μg·mL−1 (Figure 5b2). However, the 
uptake of PAAc­SiNPs at 50 μg·mL−1 concentrations was much 
slower. The fluorescent signals of PAAc­SiNPs in the HepG2 
cells could be clearly observed after they had been incubated for 
4 hours (Figure 5d1) with 50 μg·mL−1 PAAc­SiNPs, but only 
after 2 hours (Figure 5c2) for a concentration of 100 μg·mL−1. 
After incubation for 12 hours, there was no significant differ­
ence between the fluorescent signals of both concentrations, 
which suggests the uptake was almost saturated (Figure 5f).
Confocal images on 3T3­L1 cells can be found in Figure S5 
within the supporting information. A similar behaviour was 
observed by confocal microscopy. In order to observe a clear flu­
orescent signal a longer incubation time was needed with low 92 wileyonlinelibrary.com © 2012 WILEY-VCH Verlag Gconcentration of PAAc­SiNPs than with high concentration. 
And after 24 hours incubation, the fluorescent signal was satu­
rated. From which we may conclude that uptake of PAAc­SiNPs 
in HepG2 cells is faster than in 3T3­L1 cells.
To examine the spread of SiNPs within HepG2 cells, z­stack 
images collected at 0.37 μm intervals. Figure 6 displays the 
accumulation of particles within the cells with the PAAc­SiNPs 
appearing evenly distributed throughout the cytosol rather than 
attached to outer membrane only.
Figure 7 and 8 show the uptake efficiency of SiNPs in HepG2 
cells. The rightward shift in the curve represents an increase 
in fluorescent signal. This result indicatesthat the fluorescent 
signals of PAAc­SiNPs in HepG2 cells can only be detected 
when exposed to a relatively high level concentration of parti­
cles. A statistically significant increase of the relative fluores­
cence intensity occurred when the SiNPs concentration was 
greater than 100 μg·mL−1 (Figure 8c). Treatment with SiNPs 
at 100 μg·mL−1 resulted in a trend towards a time­dependent 
increase in fluorescence intensity (Figure 7c). The fluorescent 
signal increased gradually with incubation time, indicating that 
PAAc­SiNPs accumulated within the cells during incubations 
up to 72 hours.
3. Discussion
A large number of studies on the cytotoxic effects of carbon­, 
metal­, and group II–VI semiconductor­based nanoparticles 
have been reported recently,[20] however, few were on silicon mbH & Co. KGaA, Weinheim Adv. Healthcare Mater. 2012, 1, 189–198
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193wileyonlinelibrary.com© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, WeinheimAdv. Healthcare Mater. 2012, 1, 189–198
Figure 5. Confocal image of HepG2 cells incubated with a1&2) 1 hour and 24 hour incubation with medium only, b1) 50 μg·mL−1 PAAc-SiNPs 
for 1 hour, b2) 100 μg·mL−1 PAAc-SiNPs for 1 hour, c1) 50 μg·mL−1 PAAc-SiNPs for 2 hours, c2) 100 μg·mL−1 PAAc-SiNPs for 2 hours, d1) 50 μg·mL−1 
PAAc-SiNPs for 4 hours, d2) 100 μg·mL−1 PAAc-SiNPs for 4 hours, e1) 50 μg·mL−1 PAAc-SiNPs for 8 hours, e2) 100 μg·mL−1 PAAc-SiNPs for 
8 hours, f1) 50 μg·mL−1 PAAc-SiNPs for 12 hours, f2) 100 μg·mL−1 PAAc-SiNPs for 12 hours, f1) 50 μg·mL−1 PAAc-SiNPs for 24 hours, f2) 100 μg·mL−1 
PAAc-SiNPs for 24 hours. In a1-g2), Red images taken with 40× objective showing fluorescence from SiNPs (Left panel); Blue images taken with 40× 
objective showing minimal DAPI staining (middle panel); The emerge (right panel).
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Figure 6. Reconstructed 3-D confocal z-stack image of HepG2 cells 
treated with 100 μg·mL−1 PAAc-SiNPs for 24 hours (Images were col-
lected at 0.37 μm intervals with the 488 nm laser to create a stack in the 
Z axis).
Figure 7. Uptake efficiency of SiNPs in HepG2 cells with various incu-
bation times. HepG2 cells were exposed to PAAc-SiNPs for 12, 24, 36, 
48, 60, and 72 hours at two concentrations of 10 or 100 μg·mL−1. Red, 
control; blue, PAAc-SiNP 10 μg·mL−1; green, PAAc-SiNP 100 μg·mL−1. 
(a) 12 hours incubation; (b) 48 hours incubation; (c) collective results, 
which are presented as percentage of untreated control cells 10 μg·mL−1 
(white) or 100 μg·mL−1 (dark). Values are mean ± SD of the results from 
three independent experiments.
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hnanoparticles. In general, cells can survive short­term expo­
sure to low particle concentrations (<10 μg/mL) but at high 
doses, several groups have found cytotoxic effects begin to 
emerge for most nanoparticles in a dose­ and time­dependent 
manner.[20,34–40] Despite significant intracellular accumulation 
of PAAc­SiNPs in HHL5, HepG2, and 3T3­L1 cells, exposure to 
the SiNPs at <200 μg·mL−1 for up to 48 hours was not associ­
ated with any demonstrable cell toxicity (Figure 3 and 4). The 
generation of reactive oxygen species and the influence of cell 
uptake of nanoparticles are two common suggestions for raised 
cytotoxicity effects in cells.[41] In addition, Hoshino et al. dem­
onstrated that the degree of SiNP toxicity is independent of the 
nanocrystal itself but determined by the surface makeup.[42] 
Compared with nanoparticles incorporating heavy metals, such 
as cadmium or lead, PAAc SiNPs contain no heavy metals and 
are capped by a covalently bonded poly­acrylic acid layer that 
is likely to render them less toxic.[43,44] Furthermore, Goodman 
et al, have suggested that surface charge also plays a role in tox­
icity with cationic surfaces being more toxic than anionic, and 
being less biocompatible, which may be due to the affinity of 
cationic particles to the negatively charged cell membrane.[45] 
The poly­acrylic acid coating used here is indeed an anionic 
carboxylated surface layer, which should be less toxic, but may 
reduce the uptake speed as it is likely to interact with the nega­
tively charged cell membrane.
Results from some groups working on silica nanoparticles 
show low cytotoxicity of silica NPs.[46–49] Lewinski et al. sug­
gested that gold nanoparticles were applicable as a reference 
nanoparticle for low toxicity (15% reduction in cell viability, at 
200 μg·mL−1).[20] In this case, PAAc­SiNP performsbetter than 
the reference as no significant difference of cell proliferation 
and viability was found between the control samples and those 
exposed to PAAc­SiNPs at 200 μg·mL−1.
Although the interaction between nanoparticles and living 
cells remains to be understood fully, the nanoparticle internali­
zation in most cells occurs primarily through active endocytic or 
phagocytic mechanisms.[48,50] He et al. suggested the degree and 
speed of cellular uptake was diverse owing to the range of dif­
ferent nanoparticle functional groups.[51] Because of the electro­
static binding between the positively charged capping layer and 
the negative cell membrane, under fixed conditions, the greater 
the positive charge of the particles (which depends on the outer 
layer functional group), the quicker the rate of uptake.194 wileyonlinelibrary.com © 2012 WILEY-VCH Verlag GmSmall nanoparticles that facilitate delivery into the dense col­
lagen matrix of a tumor can be used as a powerful drug delivery 
agent for antitumor treatment.[1,52] However, the loading capacity 
per particle is limited, therefore a sufficient quantity of nano­
particles needs to be delivered into the target. Using both flow 
cytometry and fluorescence confocal microscopy, we have found bH & Co. KGaA, Weinheim Adv. Healthcare Mater. 2012, 1, 189–198
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Figure 8. Uptake efficiency of SiNPs in HepG2 cell with variable con-
centrations. HepG2 cell were exposed to PAAc-SiNPs at concentra-
tion of 1, 5, 10, 50, 100 and 200 μg·mL−1. Pink, control; purple SiNP 
1 μg·mL−1; green, μg·mL−1; orange PAAc-SiNP μg·mL−1; light blue, 
PAAc-SiNP μg·mL−1; blue, PAAc-SiNP 100 μg·mL−1; red, PAAc-SiNP 
200 μg·mL−1. (a) 12 hours incubation; (b) 48 hours incubation; 
(c) collective results, which are presented as a percentage of untreated 
control cells, 12 hours (white), 24 hours (light grey), and 48 hours 
(dark). Values are mean ± SD of the results from three independent 
experiments. *p < 0.05 versus control.
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12h 24h 48hthat the cells can take up SiNPs when exposed to high concen­
trations (>50 μg·mL−1). The uptake of PAAc­SiNPs in both 
human and mouse cells was found to show a time–dependent 
behaviour, which implies an activated mechanism involved in 
their uptake. PAAc­SiNPs were internalized within 2 hours, and 
the cellular accumulation increased with incubation time in the 
presence of nanoparticles in the medium. PAAc­SiNPs were 
found distributed within the cytosolic (Figure 5 and 6). The 
accumulation of PAAc­SiNPs was suggested to be due to endo­
cytosis as well as internalization of membrane and cell cycle, as 
inhibitions of such processes were found to demonstrate a very 
significant suppression in the uptake rate and on the extent of 
intracellular accumulation in various cell types.[18] During endo­
cytosis of nanoparticles, the vesicles encapsulating the nanopar­
ticles are called endosomes, which are then trafficked to various 
cellular compartments.[53] Statistically significant fluorescence 
could only be detected with flow cytometry when the particle 
concentration was greater than 100 μg·mL−1 and the incuba­
tion time longer than 24 hours. However, confocal microscopy 
can detect the concentration as low as 50 μg·mL−1 and incuba­
tion time as less as 2 hours.
We measured cellular uptake of the particles semi­ 
quantitatively by flow cytometry. The instrument gave the 
accumulated intensity of the particles fluorescent in a number 
of cells (i.e. 5000 cells). So we can know the total fluorescent 
of particles in one cell, however, not the number of particles 
in one cell. A new paper just published by Prof Dawson’s 
group took the same approach as ours.[54] In the future, if 
the fluorescence from single NP could be detected, it would 
provide a route to calculate the exact number of nanoparticles 
inside the cells.
Further study is necessary to combine luminescence and 
signals from proteins or nucleic acids that interact with cog­
nate ligands on SiNPs to determine spatiotemporal localization 
together with information about functional interaction.[18] This 
technique would offer potential application in studying and 
even manipulating intracellular interactions that are of impor­
tance in various pathways involved in regulating a variety of cel­
lular functions.
4. Conclusions
Poly­acrylic acid terminated silicon nanoparticles were 
employed as a synchronous fluorescent signal indicator. The 
effects of the silicon nanoparticles on the proliferation and via­
bility of four cell lines have been investigated: HHL5, HepG2, 
3T3­L1 pre­adipocyte and 3T3­L1 mature adipocyte. It was 
found that PAAc­SiNPs lack in vitro cellular toxicity and show 
quick accumulation in both human and mouse cells. Results 
from both confocal microscopy and flow cytometry suggest a 
time­dependent uptake of PAAc­SiNPs at higher concentra­
tions. This uptake shows a widespread cellular distribution. 
These observations may offer potential for advanced biological 
imaging techniques and targeted drug delivery.195wileyonlinelibrary.combH & Co. KGaA, Weinheim
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1965. Experimental Section
5.1. Preparation of Poly-acrylic Acid Silicon Nanoparticles
The preparation of the PAAc­SiNPs used here has been 
described previously.[25] A brief summary of the procedure is 
provided. Photoluminescent porous silicon layers were formed 
by galvanostatic anodization of a boron­doped p­Si (100) chip 
(size approx. 1.25 cm × 1.25 cm, 10 Ω·cm resistivity, Compart 
Technology, Peterborough, UK) in a 1:1 v/v solution of 48% 
aqueous hydrofluoric acid (HF) and ethanol solution. A layer 
of luminescent porous silicon was made at a relatively high cur­
rent density (5 minutes at 560 mA·cm−2). The reacted solution 
was decanted and the resulting hydrogen­terminated porous 
silicon chips were dried under vacuum. The chips were then 
introduced into a 1:9 (v: v) acrylic acid: ethanol aqueous solu­
tion. The mixture was kept under UV irradiation with magnetic 
stirring for 3–6 hours for the acrylic acid to react with the Si­H 
surface sites. The resulting solution was centrifuged and fil­
tered to remove unreacted acid and large particles. Finally the 
dry sample was obtained by reduced pressure under vacuum. 
This is a facile approach to synthesize PAAc­SiNPs.
For the silicon nanoparticles described here, the initial 
hydrogen termination layer on the etched wafer serves a dual 
role: first as a convenient molecular anchor point at which sur­
face modification may be performed, and second as an interim 
guard against oxidation in order to preserve the chemical char­
acter of the silicon core prior to subsequent functionalization 
steps.
5.2. Nanoparticle Characterization
The hydrodynamic diameter of the PAAc­SiNPs was determined 
by dynamic light scattering (DLS) with Zetasizer Nano ZS (Mal­
vern Instruments Ltd). The scattered photons were detected 
under an angle of 173°, and the relative number distribution 
was obtained. The PAAc­SiNPs were dissolved in PBS. In order 
to obtain the diameter of SiNPs as closer as possible to real size, 
ultrasonication and filtration were applied before any measure­
ment. XPS measurements were performed with a SCIENTA 
ESCA300 XPS analyser at the National Centre for Electron 
Spectroscopy and Surface Analysis (NCESS) at Daresbury Labo­
ratory. A few drops of a suspension of the PAAC­SiNPs in DI 
water were cast onto gold film. The film was introduced imme­
diately into a load­lock attached to ultra high vacuum (UHV) 
chamber in which the typical pressure was maintained below 
5 × 10−9 mbar. All spectra were acquired at normal emission 
with Al Kα radiation at 1486.7 eV, with the energy resolution E/
dE kept at ∼6 × 103. In all photoemission spectra, binding ener­
gies were referred to the Fermi edge measured on a gold foil in 
direct electrical contact with samples.
5.3. Colorimetric MTT Assay
To evaluate the cytotoxicity of PAAc­SiNPs, an MTT 
[3­(4,5­dimethylthiazol­2­yl)­2,5­diphenyltetrazolium bromide] wileyonlinelibrary.com © 2012 WILEY-VCH Verlag Gmassay was performed to determine cell viability.[35,55–58] MTT 
measures mitochondrial activity using tetrazolium salts as mito­
chondrial dehydrogenase enzymes cleave the tetrazolium ring, 
which only occurs in living cells.[59] Briefly, HHL­5, HepG2, 
3T3­L1 cells were seeded in a 96­well plate for 24 hours. Then 
the cells were treated with PAAc­SiNPs at various concentra­
tions (0, 0.1,1, 10, 50, 100 and 200 μg·mL−1) for various periods 
of time (24 and 48 hours). All experiments were repeated on at 
least three different occasions. After incubation for the speci­
fied times, the medium was removed followed by washing the 
cells with PBS. The medium was then changed and incubated 
with MTT solution (5 mg/mL) for 2 hours. The medium was 
removed, and formazan was solubilized in dimethylsulfoxide 
(DMSO). The absorbance was recorded on a microplate reader 
at the wavelength of 540 nm. The percentage of viable cells was 
estimated by comparison with the untreated control cells.
For the MTT assay, HepG2 cells were seeded at 3 × 104 per 
well (96­well plate) one day in advance. The doubling time of 
the cell is 48 hours. After 24 and 48 hour treatment, the average 
absorbance value for control cell was 0.8552 and 1.1216, respec­
tively. This indicated cell number increased in culture media. 
Absorbance was read at 540 nm, blanking on control wells.
3T3­L1 preadipocytes were incubated with Dulbecco’s modi­
fied essential medium
(DMEM) supplemented with 10% calf serum (CS) at 37 °C 
in humidified atmosphere with 5% CO2. To obtain mature adi­
pocytes, pre­adipocytes were seeded 5 × 105 per well in a 6 well 
plate. After 24 hours, the cells were stimulated to differentiate 
in differentiation medium I (DMEM supplemented with 10% 
Fetal Bovine Serum (FBS) plus 0.1 μM Dexamethasone, 0.5 mM 
IBMX and insulin 5 μg·ml−1) for 2 days. Cells were grown in 
differentiation medium II (DMEM supplemented with 10% 
Fetal Bovine Serum (FBS) plus insulin 5 μg·ml−1) for another 
2 days. Then cells were grown in DMEM supplemented with 
10% FBS. Media were changed every 2 days. After 8–10 days, 
over 90% of the cells were able to differentiate. Mature adi­
pocytes have lipid droplets, while preadipocytes do not.
5.4. Trypan Blue Staining Assay
The effect of PAAc­SiNPs on the viability of HepG2 cells was 
estimated by trypan blue staining assay. Trypan blue can stain 
dead cells, because it is only permeable to cells with compro­
mised membranes.[60] Briefly, HepG2 cells were treated with 
PAAc­SiNPs (0∼200 μg/mL) for 24 and 48 hours. Then, 30 μL 
of the cells was incubated for 5 minutes at room temperature 
with an equal volume of 0.4% (w/v) trypan blue stain (Inv­
itrogen). Cells were counted using a light microscope (TMS 
Nikon, Tokyo, Japan) and hemocytometer. Results were shown 
as the percentages of viable cells out of total cells counted.
5.5. DNA Damage Assays
DNA damage analyses, or alkaline comet assays,[33] were per­
formed to investigate DNA damage in response to PAAc­SiNPs. 
DNA lesions, including DNA single and double­strand breaks 
(SSBs, DSBs, respectively), as well as DNA base damage, bH & Co. KGaA, Weinheim Adv. Healthcare Mater. 2012, 1, 189–198
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cles using alkaline comet assays. HepG2 and HHL5 cell lines 
were investigated. Cells were exposed to H2O2 (50 μM) or SiNP 
(1, 10, 100 μg·ml−1), or the vehicle alone, and harvested at 
1 hour. Cell suspensions (1.5 × 104) were mixed with 0.6% low 
melting temperature agarose at 37 °C and immediately trans­
ferred onto a super frosted slide, which was pre­coated with 1% 
normal melting point agarose. After solidifying (15 minutes at 
4 °C), the slides were submerged in a pre­chilled lysis buffer 
(2.5 m NaCl, 100 mm Na2EDTA pH 10, 10 mm Tris Base, 
and 1% Triton X­100) at 4 °C for 60 minutes and incubated in 
an alkaline unwinding solution (300 mm NaOH, and 1 mm 
Na2EDTA, pH13) for 30 minutes at 4 °C. Damaged and undam­
aged nuclear DNA was then separated by electrophoresis for 
30 minutes at 21 V. The slides were washed in neutralisation 
buffer (0.4 M Tris­HCl, pH7.5) for 30 minutes, and stained 
with SYBR­green I. Comets were visualized using a fluores­
cence microscope, and images captured using a digital camera. 
Images were analyzed using Comet IV software and comet tail 
length was calculated as the distance between the end of nuclei 
heads and the end of each tail. Tail moments were defined as 
the product of the%DNA in each tail. Each bar represented the 
average of 60 cells ± S.E., and data are representative of experi­
ments performed three times.
5.6. Flow Cytometry
HepG2 cells were seeded on 12­well plates at a density of 5 × 104 
cells perwell and incubated at 37 °C overnight. After treatment 
with 1, 5, 10, 50, 100 or 200 μg/mL of SiNPs for 12–72 h, cells 
were harvested by trypsinization. Then cells were centrifuged at 
180 × g for 6 minutes at 4 °C, pellet washed with cold PBS then 
suspended in 400 μl cold PBS. Flow cytometry was performed 
with an Accuri C6 Flow Cytometer System using 488 nm exci­
tation with 5,000 events from each sample, and analysis was 
performed using FlowJo software.
5.7. Confocal Laser Scanning Microscopy
The nanocrystals, being highly hydrophilic, were suspended in 
sterile distilled water to being introduced in culture medium. 
HepG2 and 3T3­L1 preadipocyte cells were selected to do confocal 
images. Cells was seeded on 12­well plates with cover slips at a 
density of 5 × 104 cells per well and exposed to 50 or 100 μg·mL−1 
of SiNPs for 2–24 hours. The cells were then washed twice by PBS 
and fixed by ice­cold methanol. Cover slips with intact cells were 
inverted and mounted on a microscope slide using mounting 
gel. The images were taken under a confocal microscope (Zeiss 
LSM510 META system with an excitation wavelength 488 nm and 
emission between 550 and 650 nm) using a 40× oil immersion 
objective lens. Z­series images were collected with stepper motor.
5.8. Statistical Analysis
All data are representative of at least three independent 
experiments. Data are presented as means ± SD. Statistical © 2012 WILEY-VCH Verlag GmAdv. Healthcare Mater. 2012, 1, 189–198significance was determined using a one­way analysis of vari­
ance between the two groups. The criterion for significance was 
set at p < 0.05.
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